Literature DB >> 33634428

Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.

Xiaoze Wang1, Xuefeng Luo2, Li Yang2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33634428     DOI： 10.1007/s10620-021-06868-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Liver cirrhosis in Italy. A multicentre study on presenting modalities and the impact on health care resources. National Project on Liver Cirrhosis Group.

Authors:  M Coltorti; C Del Vecchio-Blanco; N Caporaso; C Gallo; L Castellano
Journal:  Ital J Gastroenterol       Date:  1991-01

2.  Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.

Authors:  Zoe Boyer-Diaz; Peio Aristu-Zabalza; María Andrés-Rozas; Claude Robert; Martí Ortega-Ribera; Anabel Fernández-Iglesias; Pierre Broqua; Jean-Louis Junien; Guillaume Wettstein; Jaime Bosch; Jordi Gracia-Sancho
Journal:  J Hepatol       Date:  2020-12-02       Impact factor: 25.083
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.